Racing could be next victim of net-zero battery obsession
That is the opinion of Professor Peter Dobson OBE, Department of Engineering Science, University of Oxford and three other eminent chemistry and physics professors.
Dobson added that 'far too little attention has been given to the safety issues of these potentially hazardous installations being situated close to residences and animals'.
Given the number of recent fires and explosions at lithium-ion battery storage systems in the UK and around the world, the professors' alarm is hardly surprising.
Lithium-ion batteries are 'inherently unstable' and are prone to a phenomenon called 'thermal runaway'. The result is a self-propagating fire which takes days to extinguish and belches out toxins over a wide area, not to mention the firewater run-off which has the capacity to poison an entire aquifer.
This year alone there have been fires at BESS sites in Aberdeenshire, Gloucestershire and Essex in the UK. The biggest fire in January was in California that took three days to extinguish after residents within a three-mile radius had been evacuated. It was the fifth fire in four years at the same site.
Days later there was a serious fire near Melbourne, Australia that took 70 firefighters to extinguish. A day after that, in Galway, Ireland, firefighters were hospitalised by toxic fumes and 1,300 people were evacuated at a lithium-ion battery fire.
But as a direct result of energy secretary Ed Miliband's reckless and futile race to net-zero carbon, our economy is being trashed and the safety of everyone living in the vicinity of a BESS facility is being wilfully swept under the carpet.
Miliband is well aware that there are currently no government regulations being applied to ensure the safe manufacture, installation, operation and decommissioning of lithium-ion battery facilities.
There is also no legislation preventing the use of second-life lithium-ion batteries which pose an even greater safety risk.
Should such regulations exist, one would imagine that they would stipulate that explosion-prone BESS facilities should not be placed above high-pressure gas mains, as is the case with the proposed BESS site next to Newmarket.
Miliband passed this development in spite of the Planning Inspectorate turning it down. Not surprisingly, he has now passed the buck to Cambridge and Suffolk county councils.
They will have to decide, without the guidance of any government regulations, whether this scheme is safe. And my guess is that they will not have the expertise or resources to make a sound, or indeed safe, decision.
In addition to the danger this BESS facility holds for Newmarket, there are three wider moral issues that the councils should not turn a blind eye to, even if they are way out of their depth.
The first is that these BESS sites are required because we are increasingly reliant on unpredictable renewable power that is not guaranteed to create enough electricity when it is needed
Secondly, there is a question of the morality of these facilities, which will buy cheap electricity off the National Grid, store it at times of peak output and then resell it back to the Grid at a higher price.
There is also another more poignant moral issue. About 70 per cent of all BESS units and components are made in China, where they care not how the electricity is generated during the manufacturing process. Add to that the environmental damage created by mining lithium and the lack of recycling centres anywhere in the world for these batteries.
Given that it is two to three times more expensive to recover the rare metals from the batteries than mine more, it is clear the environmental damage caused by their production will only increase.
In effect, we are simply exporting our climate-change impact across the world to meet a spurious target.
The councils may also wish to consider the possibility that forced labour is used to create them. Government assurances that the Uyghur people are not being exploited by the Chinese to produce goods for the UK are nothing more than empty, weasel words.
There is also the security issue of covering our best agricultural land with Chinese hardware. It would be ludicrous not to assume that the Chinese government will be permeating these batteries with microchips obedient to Beijing. So how is that going to play out?
The experts believe that 'there is a growing suspicion that details [of BESS fires] are being suppressed'.
In layman's terms, lithium-ion battery failures could well be the biggest environmental disaster this country has ever witnessed. Especially if you locate them near gas mains!
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WIRED
a day ago
- WIRED
The First Widespread Cure for HIV Could Be in Children
Aug 1, 2025 9:19 AM Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their viral loads to undetectable levels and then come off the medicine. An ARV tablet being held in Kisumu, Kenya, on April 24, 2025. Photograph:For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred children who had acquired HIV from their mothers, either during pregnancy, childbirth, or breastfeeding. After putting the children on antiretroviral drugs early in their lives to control the virus, Goulder and his colleagues were keen to monitor their progress and adherence to standard antiretroviral treatment, which stops HIV from replicating. But over the following decade, something unusual happened. Five of the children stopped coming to the clinic to collect their drugs, and when the team eventually tracked them down many months later, they appeared to be in perfect health. 'Instead of their viral loads being through the roof, they were undetectable,' says Goulder. 'And normally HIV rebounds within two or three weeks.' In a study published last year, Goulder described how all five remained in remission, despite having not received regular antiretroviral medication for some time, and in one case, up to 17 months. In the decades-long search for an HIV cure, this offered a tantalizing insight: that the first widespread success in curing HIV might not come in adults, but in children. At the recent International AIDS Society conference held in Kigali, Rwanda, in mid-July, Alfredo Tagarro, a pediatrician at the Infanta Sofia University Hospital in Madrid, presented a new study showing that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of life ultimately suppress the HIV viral reservoir—the number of cells harboring the virus's genetic material—to negligible levels. 'Children have special immunological features which makes it more likely that we will develop an HIV cure for them before other populations,' says Tagarro. His thoughts were echoed by another doctor, Mark Cotton, who directs the children's infectious diseases clinical research unit at the University of Stellenbosch, Cape Town. 'Kids have a much more dynamic immune system,' says Cotton. 'They also don't have any additional issues like high blood pressure or kidney problems. It makes them a better target, initially, for a cure.' According to Tagarro, children with HIV have long been 'left behind' in the race to find a treatment that can put HIV-positive individuals permanently into remission. Since 2007, 10 adults are thought to have been cured, having received stem cell transplants to treat life-threatening blood cancer, a procedure which ended up eliminating the virus. Yet with such procedures being both complex and highly risky—other patients have died in the aftermath of similar attempts—it is not considered a viable strategy for specifically targeting HIV. Instead, like Goulder, pediatricians have increasingly noticed that after starting antiretroviral treatment early in life, a small subpopulation of children then seem able to suppress HIV for months, years, and perhaps even permanently with their immune system alone. This realization initially began with certain isolated case studies: the 'Mississippi baby' who controlled the virus for more than two years without medication, and a South African child who was considered potentially cured having kept the virus in remission for more than a decade. Cotton says he suspects that between 10 and 20 percent of all HIV-infected children would be capable of controlling the virus for a significant period of time, beyond the typical two to three weeks, after stopping antiretrovirals. Goulder is now launching a new study to try and examine this phenomenon in more detail, taking 19 children in South Africa who have suppressed HIV to negligible levels on antiretrovirals, stopping the drugs, and seeing how many can prevent the virus from rebounding, with the aim of understanding why. To date, he says that six of them have been able to control the virus without any drugs for more than 18 months. Based on what he's seen so far, he has a number of ideas about what could be happening. In particular, it appears that boys are more likely to better control the virus due to a quirk of gender biology to do with the innate immune system, the body's first-line defense against pathogens. 'The female innate immune system both in utero and in childhood is much more aggressive than the male equivalent when it encounters and senses viruses like HIV,' says Goulder. 'Usually that's a good thing, but because HIV infects activated immune cells, it actually seems to make girls more vulnerable to being infected.' In addition, Goulder notes that because female fetuses share the same innate immune system as their mothers, the virus transmitted to them is an HIV strain that has become resistant to the female innate immune response. There could also be other explanations for the long-lasting suppression seen in some children. In some cases, Goulder has observed that the transmitted strain of HIV has been weakened through needing to undergo changes to circumvent the mother's adaptive immune response, the part of the immune system which learns to target specific viruses and other pathogens. He has also noted that male infants experience particularly large surges of testosterone in the first six months of life—a period known as 'mini-puberty'—which can enhance their immune system in various ways that help them fight the virus. Such revelations are particularly tantalizing as HIV researchers are starting to get access to a far more potent toolbox of therapeutics. Leading the way are so-called bNAbs, or broadly neutralizing antibodies, which have the ability to recognize and fight many different strains of HIV, as well as stimulating the immune system to destroy cells where HIV is hiding. There are also a growing number of therapeutic vaccines in development that can train the immune system's T cells to target and destroy HIV reservoirs. Children tend to respond to various vaccines better than adults, and Goulder says that if some children are already proving relatively adept at controlling the virus on the back of standard antiretrovirals, these additional therapeutics could give them the additional assistance they need to eradicate HIV altogether. In the coming years, this is set to be tested in several clinical trials. Cotton is leading the most ambitious attempt, which will see HIV-infected children receive a combination of antiretroviral therapy, three bNAbs, and a vaccine developed by the University of Oxford, while in a separate trial, Goulder is examining the potential of a different bNAb together with antiretrovirals to see whether it can help more children achieve long-term remission. 'We think that adding the effects of these broadly neutralizing antibodies to antiretrovirals will help us chip away at what is needed to achieve a cure,' says Goulder. 'It's a little bit like with leukemia, where treatments have steadily improved, and now the outlook for most children affected is incredibly good. Realistically in most cases, curing HIV probably requires a few hits from different angles, impacting the way that the virus can grow, and tackling it with different immune responses at the same time to essentially force it into a cul-de-sac that it can't escape from.' Children are also being viewed as the ideal target population for an even more ambitious experimental treatment, a one-time gene therapy that delivers instructions directing the body's own muscle cells to produce a continuous stream of bNAbs, without the need for repeated infusions. Maurico Martins, an associate professor at the University of Florida, who is pioneering this new approach, feels that it could represent a particularly practical strategy for low-income countries where HIV transmission to children is particularly rife, and mothers often struggle to keep their children on repeated medication. 'In regions like Uganda or parts of South Africa where this is very prevalent, you could also give this therapy to a baby right after birth as a preventative measure, protecting the newborn child against acquisition of HIV through breastfeeding and maybe even through sexual intercourse later in life,' says Martins. While Martins also hopes that gene therapy could benefit HIV-infected adults in future, he feels it has more of a chance of initially succeeding in children because their nascent immune systems are less likely to launch what he calls an anti-drug response that can destroy the therapeutic bNAbs. 'It's very difficult for most antibodies to recognize the HIV envelope protein because it's buried deep within a sugar coat,' says Martins. 'To overcome that, these bNAbs carry a lot of mutations and extensions to their arms which allow them to penetrate that sugar coat. But the problem then is that they're often viewed by your own immune system as foreign, and it starts making these anti-bNAb antibodies.' But when Martins tested the therapy in newborn rhesus macaques, it was far more effective. 'We found that the first few days or two weeks after birth comprised a sort of sweet spot for this gene therapy,' he says. 'And that's why this could really work very well in treating and preventing pediatric HIV infections.' Like many HIV scientists, Martins has run into recent funding challenges, with a previous commitment from the National Institutes of Health to support a clinical trial of the novel therapy in HIV-infected children being withdrawn. However, he is hoping that the trial will still go ahead. 'We're now talking with the Gates Foundation to see whether they can sponsor it,' he says. While children still comprise the minority of overall HIV infections, being able to cure them may yield further insights that help with the wider goal of an overall curative therapy. 'We can learn a lot from them because they are different,' says Goulder. 'I think we can learn how to achieve a cure in kids if we continue along this pathway, and from there, that will have applications in adults as well.'
Yahoo
2 days ago
- Yahoo
Sleepiness Could Be Triggered by a Power Overload in Our Brain
Denied of sleep, we find it but impossible to keep our eyes open and our thoughts focused. A new study based on fruit flies may have pin-pointed the origins of this biological lullaby, and with it a deeper understanding of our need for rest on a cellular level. Researchers from the University of Oxford in the UK have identified our cell's mitochondria as responsible for signaling when the body has to get some shut-eye as soon as possible. These tiny power generators cause a kind of metabolic overload in sleep-regulating neurons, the researchers suggest, which in simple terms indicates when our brain is running on empty. Through sleep, this overload can be reset, ensuring the brain remains in a healthy state. Related: "We set out to understand what sleep is for, and why we feel the need to sleep at all," says physiologist Gero Miesenböck. "Despite decades of research, no one had identified a clear physical trigger." "Our findings show that the answer may lie in the very process that fuels our bodies: aerobic metabolism." The team studied neurons responsible for regulating sleep in fruit flies, which have enough biological similarities to humans to make them useful for research. Through a comparison of well-rested and sleep-deprived fruit flies, the researchers identified differences in gene activity and electrical signaling. Overloaded mitochondria in sleep-deprived brains were found to shed electrons, increasing the generation of harmful waste products. The sleep-regulating neurons respond to these molecules by going into overdrive, making sleep a top biological priority. "You don't want your mitochondria to leak too many electrons," says neuroscientist Raffaele Sarnataro. "When they do, they generate reactive molecules that damage cells." Genetically engineering flies with a higher production of electrons in their sleep-regulating cells resulted in fruit flies that also slept more. Similarly, flies with a reduced level of electron generation slept less. There are, of course, other pressures on sleep, from how many coffees you have per day to the alignment of your circadian rhythm – the internal schedule that tells your body when it's time for bed. But now we have an actual cellular mechanism controlling sleep, and showing why we can't do without it. Anything new we learn about sleep can inform the treatment of sleep disorders and even neurological conditions such as Alzheimer's. These diseases are closely linked to sleep and the way it protects the brain, and connections to mitochondria could be something for future studies to investigate. The study also joins some of the dots between metabolism, sleep, and lifespan. Smaller animals tend to sleep more and live shorter lives, and the activity of mitochondria – and the waste that needs clearing up – could be part of the reason why. "This research answers one of biology's big mysteries," says Sarnataro. "Why do we need sleep? The answer appears to be written into the very way our cells convert oxygen into energy." The research has been published in Nature. Related News Study Reveals Key Way to Slow Chronic Illness in Old Age Liver Cancer Predicted to Double by 2050, But There Is Hope One Weekend Habit May Cut Risk of Heart-Related Death by 33%, Study Finds Solve the daily Crossword
Yahoo
2 days ago
- Yahoo
Sticky goo in 2,500-year-old bronze jars finally identified, settling 70-year debate
When you buy through links on our articles, Future and its syndication partners may earn a commission. Globs of sticky goo discovered in the bottom of 2,500-year-old bronze jars from southern Italy have been chemically identified, settling a 70-year archaeological debate. It's honey — the sweet leftovers of an offering to an ancient god. A team of chemists and archaeologists used cutting-edge analysis techniques to test the paste-like residue. They concluded that the jars, which were found in the sixth-century-B.C. city of Paestum, originally contained honeycomb. "What I find interesting is that the ancient Greeks did think that honey was a superfood," study lead author Luciana da Costa Carvalho, a chemist at the University of Oxford, said in a video. The researchers published their findings Wednesday (July 30) in the Journal of the American Chemical Society. Honey and honeybees were important in ancient Greek and Roman medicine, rituals, cosmetics and food. So when archaeologists found eight bronze jars in an underground shrine in 1954, they assumed that the jars contained honey as a symbol of immortality. Despite at least four attempts over seven decades to confirm the presence of the sticky, sweet substance, no evidence of sugars was ever found. Related: Does honey ever go bad? But Carvalho and colleagues decided to take advantage of recent advances in chemical analysis techniques and to reopen the question of the gooey substance's origin. Using mass spectrometry, a technique that can identify different molecules and compounds, Carvalho and colleagues identified intact hexose sugars in the ancient jar residue for the first time. Fresh honey is about 79% hexose sugars, the researchers wrote in the study, with fructose being the most abundant. An analysis of the proteins in the ancient sample revealed the presence of royal jelly, a milky secretion made by worker bees. The researchers also recovered peptides — short amino acid chains that are smaller versions of proteins — unique to one species of honeybee: the European honeybee (Apis mellifera). Adding up these analyses, the researchers wrote that the study presents the first direct molecular evidence supporting the presence of honey, likely offered as honeycombs. "The amount of sugar in the ancient residue is very low compared to modern honey," Carvalho told Live Science in an email. "I think the residue tastes like washed honeycomb but slightly more acidic," Carvalho said, although she did not actually try it. The researchers also identified copper ions in the honey mixture. Because these ions are biocidal, meaning they can kill microorganisms, "their presence would have contributed to the preservations of sugars on the surface of the residue," Carvalho said, potentially explaining how the honey lasted thousands of years. The analysis of the goop can help archaeologists better understand ancient rituals and shrines. The jars were found in an underground shrine, also called a heroon, at Paestum. The heroon also included a large, wooden table with wool-wrapped iron rods placed on top. RELATED STORIES —Panathenaic prize amphora: A pot brimming with olive oil awarded at the ancient Greek Olympics —Depiction of Trojan War hero Ajax found in 1,800-year-old submerged building in Greece —Ancient Greeks may have built 'disability ramps' on some temples The offering may have been made to Is of Helice, the mythical founder of the ancient Greek city of Sybaris, located in what today is the arch of Italy's boot. When Sybaris was destroyed in the sixth century B.C., its inhabitants fled and founded a city called Poseidonia. But when the Romans took it over in the third century B.C., they renamed the city Paestum. The new study shows that "there is merit in reanalyzing museum collections because analytical techniques continue to develop," Carvalho said in the video. Solve the daily Crossword
